Abstract
Antibodies are exceptionally versatile molecules with remarkable flexibility in their binding properties. Their natural targets range from small-molecule toxins, across viruses of different sizes, to bacteria and large multicellular parasites. The molecular determinants bound by antibodies include proteins, peptides, carbohydrates, nucleic acids, lipids and even synthetic molecules that have never existed in nature. Membrane-anchored antibodies also serve as receptors on the surface of the B cells that produce them. Despite recent structural insights, there is still no unifying molecular mechanism to explain how antibody targets (antigens) trigger the activation of these B-cell receptors (BCRs). After cognate antigen encounter, somatic hypermutation and class-switch recombination allow BCR affinity maturation and immunoglobulin class-specific responses, respectively. This raises the fundamental question of how one receptor activation mechanism can accommodate a plethora of variant receptors and ligands, and how it can ensure that individual B cells remain responsive to antigen after somatic hypermutation and class switching. There is still no definite answer. Here we give a brief historical account of the different models proposed to explain BCR triggering and discuss their merit in the context of the current knowledge of the structure of BCRs, their dynamic membrane distribution, and recent biochemical and cell biological insights.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burnet, F. M. A modification of Jerne’s theory of antibody production using the concept of clonal selection (reprinted from Australian Journal of Science Vol. 20, 1957). Nat. Immunol. 8, 1024–1026 (2007).
Sakano, H., Maki, R., Kurosawa, Y., Roeder, W. & Tonegawa, S. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature 286, 676–683 (1980).
Eisen, H. N. Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses. Cancer Immunol. Res. 2, 381–392 (2014).
Metzger, H. Transmembrane signaling: the joy of aggregation. J. Immunol. 149, 1477–1487 (1992). This paper presents a synthesis of much data suggesting that aggregation of receptors, including the BCR, can serve as a generic mechanism for transmembrane signaling.
Yang, J. & Reth, M. The dissociation activation model of B cell antigen receptor triggering. FEBS Lett. 584, 4872–κ4877 (2010).
Tolar, P. & Pierce, S. K. A conformation-induced oligomerization model for B cell receptor microclustering and signaling. Curr. Top. Microbiol. Immunol. 340, 155–169 (2010). This is the first suggestion of a conformation-induced oligomerization model for BCR activation.
Ferapontov, A. et al. Antigen footprint governs activation of the B cell receptor. Nat. Commun. 14, 976 (2023). This is the first suggestion that kinetic segregation may control BCR activation and that it is governed by the footprint of the antigen.
Khan, W. N. et al. Defective B cell development and function in Btk-deficient mice. Immunity 3, 283–299 (1995).
Lam, K. P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073–1083 (1997).
Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787–800 (2004).
Ohnishi, K. & Melchers, F. The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 4, 849–856 (2003).
Ziegler, C. G. K. et al. Constitutive activation of the B cell receptor underlies dysfunctional signaling in chronic lymphocytic leukemia. Cell Rep. 28, 923–937 (2019).
Gomes de Castro, M. A. et al. Differential organization of tonic and chronic B cell antigen receptors in the plasma membrane. Nat. Commun. 10, 820 (2019).
Duhren-von Minden, M. et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489, 309–312 (2012).
Minici, C. et al. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia. Nat. Commun. 8, 15746 (2017).
Zikherman, J., Parameswaran, R. & Weiss, A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489, 160–164 (2012).
Schweighoffer, E. et al. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 38, 475–488 (2013).
Fanger, M. W., Hart, D. A., Wells, J. V. & Nisonoff, A. Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents. J. Immunol. 105, 1484–1492 (1970).
Monroe, J. G. & Cambier, J. C. B cell activation. I. Anti-immunoglobulin-induced receptor cross-linking results in a decrease in the plasma membrane potential of murine B lymphocytes. J. Exp. Med. 157, 2073–2086 (1983).
Schreiner, G. F. & Unanue, E. R. Membrane and cytoplasmic changes in B lymphocytes induced by ligand–surface immunoglobulin interaction. Adv. Immunol. 24, 37–165 (1976).
Edelman, G. M. Dissociation of γ-globulin. J. Am. Chem. Soc. 81, 3155–3156 (2002).
Porter, R. R. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem. J. 73, 119–126 (1959).
Metzger, H. Effect of antigen binding on the properties of antibody. Adv. Immunol. 18, 169–207 (1974).
Murphy, K., Weaver, C., Berg, L. & Barton, G. Janeway’s Immunobiology 10th edn (W.W. Norton & Company, 2022).
Kato, Y. et al. Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo. Immunity 53, 548–563.e548 (2020).
Burger, J. A. & Chiorazzi, N. B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol. 34, 592–601 (2013).
Tolar, P., Hanna, J., Krueger, P. D. & Pierce, S. K. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity 30, 44–55 (2009).
Kim, Y. M. et al. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc. Natl Acad. Sci. USA 103, 3327–3332 (2006).
Schamel, W. W. & Reth, M. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13, 5–14 (2000).
Qi, S., Krogsgaard, M., Davis, M. M. & Chakraborty, A. K. Molecular flexibility can influence the stimulatory ability of receptor–ligand interactions at cell–cell junctions. Proc. Natl Acad. Sci. USA 103, 4416–4421 (2006).
Su, X. et al. Phase separation of signaling molecules promotes T cell receptor signal transduction. Science 352, 595–599 (2016).
Li, Y. et al. Structural insights into immunoglobulin M. Science 367, 1014–1017 (2020).
Sharp, T. H. et al. Insights into IgM-mediated complement activation based on in situ structures of IgM–C1–C4b. Proc. Natl Acad. Sci. USA 116, 11900–11905 (2019).
Ugurlar, D. et al. Structures of C1–IgG1 provide insights into how danger pattern recognition activates complement. Science 359, 794–797 (2018).
Dong, Y. et al. Structural principles of B-cell antigen receptor assembly. Preprint at bioRxiv https://doi.org/10.1101/2022.08.13.503858 (2022).
Davis, S. J. & van der Merwe, P. A. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17, 177–187 (1996). This paper presents the kinetic segregation model for TCR activation.
Davis, S. J. & van der Merwe, P. A. The kinetic-segregation model: TCR triggering and beyond. Nat. Immunol. 7, 803–809 (2006).
Thomas, M. L. The regulation of B- and T-lymphocyte activation by the transmembrane protein tyrosine phosphatase CD45. Curr. Opin. Cell Biol. 6, 247–252 (1994).
Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I. & Yamamoto, T. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187, 1343–1348 (1998).
Smith, K. G., Tarlinton, D. M., Doody, G. M., Hibbs, M. L. & Fearon, D. T. Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187, 807–811 (1998).
Lu, W., Skrzypczynska, K. M. & Weiss, A. Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway. Proc. Natl Acad. Sci. USA 118, e2108957118 (2021).
Wan, Z. et al. The activation of IgM- or isotype-switched IgG- and IgE-BCR exhibits distinct mechanical force sensitivity and threshold. eLife 4, e06925 (2015).
Chen, Q., Menon, R., Calder, L. J., Tolar, P. & Rosenthal, P. B. Cryomicroscopy reveals the structural basis for a flexible hinge motion in the immunoglobulin M pentamer. Nat. Commun. 13, 6314 (2022).
Hobeika, E., Maity, P. C. & Jumaa, H. Control of B cell responsiveness by isotype and structural elements of the antigen receptor. Trends Immunol. 37, 310–320 (2016).
Amendt, T. et al. Primary immune responses and affinity maturation are controlled by IgD. Front. Immunol. 12, 709240 (2021).
Setz, C. S. et al. Pten controls B-cell responsiveness and germinal center reaction by regulating the expression of IgD BCR. EMBO J. 38, e100249 (2019).
Ubelhart, R. et al. Responsiveness of B cells is regulated by the hinge region of IgD. Nat. Immunol. 16, 534–543 (2015).
Noviski, M. et al. IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate. eLife 7, e35074 (2018).
Haniuda, K., Fukao, S., Kodama, T., Hasegawa, H. & Kitamura, D. Autonomous membrane IgE signaling prevents IgE-memory formation. Nat. Immunol. 17, 1109–1117 (2016).
Yang, Z. et al. Regulation of B cell fate by chronic activity of the IgE B cell receptor. eLife 5, e21238 (2016).
Knight, A. M., Lucocq, J. M., Prescott, A. R., Ponnambalam, S. & Watts, C. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Igα/Igβ dimer. EMBO J. 16, 3842–3850 (1997).
Engels, N. et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat. Immunol. 10, 1018–1025 (2009).
Engels, N. & Wienands, J. Memory control by the B cell antigen receptor. Immunol. Rev. 283, 150–160 (2018).
Minguet, S., Dopfer, E. P. & Schamel, W. W. Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR). Int. Immunol. 22, 205–212 (2010).
Avalos, A. M. et al. Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells. J. Exp. Med. 211, 365–379 (2014).
Volkmann, C. et al. Molecular requirements of the B-cell antigen receptor for sensing monovalent antigens. EMBO J. 35, 2371–2381 (2016).
van Dongen, M. A., Dougherty, C. A. & Banaszak Holl, M. M. Multivalent polymers for drug delivery and imaging: the challenges of conjugation. Biomacromolecules 15, 3215–3234 (2014).
Zapadka, K. L., Becher, F. J., Gomes Dos Santos, A. L. & Jackson, S. E. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interf. Focus 7, 20170030 (2017).
Yang, J. & Reth, M. Oligomeric organization of the B-cell antigen receptor on resting cells. Nature 467, 465–469 (2010). This is the first suggestion of the dissociation–activation model for BCR activation.
Dintzis, H. M., Dintzis, R. Z. & Vogelstein, B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl Acad. Sci. USA 73, 3671–3675 (1976).
Veneziano, R. et al. Role of nanoscale antigen organization on B-cell activation probed using DNA origami. Nat. Nanotechnol. 15, 716–723 (2020).
Mukherjee, S. et al. Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases. Sci. Signal. 6, ra1 (2013).
Stepanek, O., Draber, P., Drobek, A., Horejsi, V. & Brdicka, T. Nonredundant roles of Src-family kinases and Syk in the initiation of B-cell antigen receptor signaling. J. Immunol. 190, 1807–1818 (2013).
Natkanski, E. et al. B cells use mechanical energy to discriminate antigen affinities. Science 340, 1587–1590 (2013).
Lavoie, T. B., Drohan, W. N. & Smith-Gill, S. J. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J. Immunol. 148, 503–513 (1992).
Tsourkas, P. K., Liu, W., Das, S. C., Pierce, S. K. & Raychaudhuri, S. Discrimination of membrane antigen affinity by B cells requires dominance of kinetic proofreading over serial engagement. Cell Mol. Immunol. 9, 62–74 (2012).
Brooks, J. F. et al. Molecular basis for potent B cell responses to antigen displayed on particles of viral size. Nat. Immunol. 24, 1762–1777 (2023).
Batista, F. D., Iber, D. & Neuberger, M. S. B cells acquire antigen from target cells after synapse formation. Nature 411, 489–494 (2001).
Nowosad, C. R., Spillane, K. M. & Tolar, P. Germinal center B cells recognize antigen through a specialized immune synapse architecture. Nat. Immunol. 17, 870–877 (2016).
Tolar, P. Cytoskeletal control of B cell responses to antigens. Nat. Rev. Immunol. 17, 621–634 (2017).
Khalil, A. M., Cambier, J. C. & Shlomchik, M. J. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science 336, 1178–1181 (2012).
Al Qaraghuli, M. M., Kubiak-Ossowska, K., Ferro, V. A. & Mulheran, P. A. Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response. Sci. Rep. 10, 13696 (2020).
Shen, Z. et al. Conformational change within the extracellular domain of B cell receptor in B cell activation upon antigen binding. eLife 8, e42271 (2019).
Scharf, L. et al. Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody. Proc. Natl Acad. Sci. 110, 6049–6054 (2013).
Ma, X. et al. Cryo-EM structures of two human B cell receptor isotypes. Science 377, 880–885 (2022). This is one of three contemporaneous papers showing the first atomic-resolution structures of the BCR complex solubilized in detergent.
Su, Q. et al. Cryo-EM structure of the human IgM B cell receptor. Science 377, 875–880 (2022). This is one of three contemporaneous papers showing the first atomic-resolution structures of the BCR complex solubilized in detergent.
Shaw, A. et al. Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies. Nat. Nanotechnol. 14, 184–190 (2019).
Resch-Genger, U. et al. How to improve quality assurance in fluorometry: fluorescence-inherent sources of error and suited fluorescence standards. J. Fluoresc. 15, 337–362 (2005).
Baumgart, F., Arnold, A. M., Rossboth, B. K., Brameshuber, M. & Schutz, G. J. What we talk about when we talk about nanoclusters. Methods Appl. Fluoresc. 7, 013001 (2018).
Maity, P. C. et al. B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation. Sci. Signal. 8, ra93 (2015).
Klasener, K., Maity, P. C., Hobeika, E., Yang, J. & Reth, M. B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk. eLife 3, e02069 (2014).
Lee, J., Sengupta, P., Brzostowski, J., Lippincott-Schwartz, J. & Pierce, S. K. The nanoscale spatial organization of B-cell receptors on immunoglobulin M- and G-expressing human B-cells. Mol. Biol. Cell 28, 511–523 (2017).
Mattila, P. K. et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity 38, 461–474 (2013).
Gasparrini, F. et al. Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling. EMBO J. 35, 258–280 (2016).
Garcia-Parajo, M. F., Cambi, A., Torreno-Pina, J. A., Thompson, N. & Jacobson, K. Nanoclustering as a dominant feature of plasma membrane organization. J. Cell Sci. 127, 4995–5005 (2014).
Nicolson, G. L. & Ferreira de Mattos, G. The fluid-mosaic model of cell membranes: A brief introduction, historical features, some general principles, and its adaptation to current information. Biochim. Biophys. Acta Biomembr. 1865, 184135 (2023).
Bernardino de la Serna, J., Schutz, G. J., Eggeling, C. & Cebecauer, M. There is no simple model of the plasma membrane organization. Front. Cell Dev. Biol. 4, 106 (2016).
Shevchenko, A. & Simons, K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11, 593–598 (2010).
Lingwood, D. & Simons, K. Lipid rafts as a membrane-organizing principle. Science 327, 46–50 (2010).
Cheng, P. C., Dykstra, M. L., Mitchell, R. N. & Pierce, S. K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549–1560 (1999).
Aman, M. J. & Ravichandran, K. S. A requirement for lipid rafts in B cell receptor induced Ca2+ flux. Curr. Biol. 10, 393–396 (2000).
Cheng, P. C., Brown, B. K., Song, W. & Pierce, S. K. Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J. Immunol. 166, 3693–3701 (2001).
Stone, M. B., Shelby, S. A., Nunez, M. F., Wisser, K. & Veatch, S. L. Protein sorting by lipid phase-like domains supports emergent signaling function in B lymphocyte plasma membranes. eLife 6, e19891 (2017).
Nunez, M. F., Wisser, K. & Veatch, S. L. Synergistic factors control kinase-phosphatase organization in B-cells engaged with supported bilayers. Mol. Biol. Cell 31, 667–682 (2020).
Petrie, R. J., Schnetkamp, P. P., Patel, K. D., Awasthi-Kalia, M. & Deans, J. P. Transient translocation of the B cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165, 1220–1227 (2000).
Awasthi-Kalia, M., Schnetkamp, P. P. & Deans, J. P. Differential effects of filipin and methyl-β-cyclodextrin on B cell receptor signaling. Biochem. Biophys. Res. Commun. 287, 77–82 (2001).
Shelby, S. A., Castello-Serrano, I., Wisser, K. C., Levental, I. & Veatch, S. L. Membrane phase separation drives responsive assembly of receptor signaling domains. Nat. Chem. Biol. 19, 750–758 (2023).
Treanor, B. et al. The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor. Immunity 32, 187–199 (2010).
Becker, M., Hobeika, E., Jumaa, H., Reth, M. & Maity, P. C. CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor. Proc. Natl Acad. Sci. USA 114, 5231–5236 (2017).
Kwak, K. et al. B cell responses to membrane-presented antigens require the function of the mechanosensitive cation channel Piezo1. Sci. Signal. 16, eabq5096 (2023).
Saltukoglu, D. et al. Plasma membrane topography governs the 3D dynamic localization of IgM B cell antigen receptor clusters. EMBO J. 42, e112030 (2023).
Schmidt, R. et al. MINFLUX nanometer-scale 3D imaging and microsecond-range tracking on a common fluorescence microscope. Nat. Commun. 12, 1478 (2021).
Lu, C. H. et al. Lightsheet localization microscopy enables fast, large-scale, and three-dimensional super-resolution imaging. Commun. Biol. 2, 177 (2019).
Putney, J. W. Jr. Capacitative calcium entry: sensing the calcium stores. J. Cell Biol. 169, 381–382 (2005).
Berridge, M. J., Bootman, M. D. & Roderick, H. L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517–529 (2003).
Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179–185 (2006).
Berry, C. T. et al. BCR-induced Ca2+ signals dynamically tune survival, metabolic reprogramming, and proliferation of naive B cells. Cell Rep. 31, 107474 (2020).
Kurosaki, T. Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol. 17, 555–592 (1999).
Zhou, D. & Zhu, J. Structure of CD148 fibronectin type III domain 1 and 2. Protein Data Bank https://doi.org/10.2210/pdb7U08/pdb (2022).
Izumi, K., Yoshida, M., Hayashi, F., Yokoyama, S. & RIKEN Structural Genomics/Proteomics Initiative (RSGI) Solution structure of the fourth fn3 domain of human receptor-type tyrosine-protein phosphatase eta. Protein Data Bank https://doi.org/10.2210/pdb2DLE/pdb (2006).
Barr, A. J. et al. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136, 352–363 (2009).
Chang, V. T. et al. Initiation of T cell signaling by CD45 segregation at ‘close contacts’. Nat. Immunol. 17, 574–582 (2016).
Symons, A., Willis, A. C. & Barclay, A. N. Domain organization of the extracellular region of CD45. Protein Eng. 12, 885–892 (1999).
Nam, H. J., Poy, F., Saito, H. & Frederick, C. A. Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J. Exp. Med. 201, 441–452 (2005).
Harris, L. J., Skaletsky, E. & McPherson, A. Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 275, 861–872 (1998).
Mimoto, F. et al. Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131). Protein Eng. Des. Sel. 26, 589–598 (2013).
Susa, K. J., Rawson, S., Kruse, A. C. & Blacklow, S. C. Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81. Science 371, 300–305 (2021).
Gilbert, H. E., Asokan, R., Holers, V. M. & Perkins, S. J. The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. J. Mol. Biol. 362, 1132–1147 (2006).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022).
Galaxy, C. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 50, W345–W351 (2022).
Bhattacharya, A. A., Curry, S. & Franks, N. P. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J. Biol. Chem. 275, 38731–38738 (2000).
Rodnin, M. V. et al. Histidine protonation and conformational switching in diphtheria toxin translocation domain. Toxins 15, 410 (2023).
Venkadesh, S., Mandal, P. K. & Gautham, N. Crystal structure of the decamer CGGGCGCCCG forming a Holliday junction. Protein Data Base https://doi.org/10.2210/pdb3hqe/pdb (2009).
Eichert, A. et al. The crystal structure of an ‘all locked’ nucleic acid duplex. Nucleic Acids Res. 38, 6729–6736 (2010).
Nielsen, K. M. E., Petersen, M., Hakansson, A. E., Wengel, J. & Jacobsen, J. P. α-L-LNA (α-L-ribo configured locked nucleic acid) recognition of DNA: an NMR spectroscopic study. Chemistry 8, 3001–3009 (2002).
Hombach, J., Tsubata, T., Leclercq, L., Stappert, H. & Reth, M. Molecular components of the B-cell antigen receptor complex of the IgM class. Nature 343, 760–762 (1990).
Reth, M. Antigen receptor tail clue. Nature 338, 383–384 (1989).
Cambier, J. C. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL). Immunol. Today 16, 110 (1995).
Dong, Y. et al. Structural principles of B cell antigen receptor assembly. Nature 612, 156–161 (2022). This is one of three contemporaneous papers showing the first atomic-resolution structures of the BCR complex solubilized in detergent.
Pao, L. I. & Famiglietti, S. J. & Cambier, J. C. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction. J. Immunol. 160, 3305–3314 (1998).
Burkhardt, A. L., Brunswick, M., Bolen, J. B. & Mond, J. J. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc. Natl Acad. Sci. USA 88, 7410–7414 (1991).
Mocsai, A., Ruland, J. & Tybulewicz, V. L. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat. Rev. Immunol. 10, 387–402 (2010).
Chiu, C. W., Dalton, M., Ishiai, M., Kurosaki, T. & Chan, A. C. BLNK: molecular scaffolding through ‘cis’-mediated organization of signaling proteins. EMBO J. 21, 6461–6472 (2002).
Fu, C., Turck, C. W., Kurosaki, T. & Chan, A. C. BLNK: a central linker protein in B cell activation. Immunity 9, 93–103 (1998).
Goitsuka, R. et al. Cutting edge: BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius. J. Immunol. 161, 5804–5808 (1998).
Wienands, J. et al. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 188, 791–795 (1998).
Fu, C. & Chan, A. C. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cγ, Grb2, and Vav after B cell antigen receptor activation. J. Biol. Chem. 272, 27362–27368 (1997).
Hashimoto, S. et al. Identification of the SH2 domain binding protein of Bruton’s tyrosine kinase as BLNK — functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94, 2357–2364 (1999).
Ishiai, M. et al. BLNK required for coupling Syk to PLCγ2 and Rac1-JNK in B cells. Immunity 10, 117–125 (1999).
Su, Y.-W. et al. Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur. J. Immunol. 29, 3702–3711 (1999).
Burbage, M. et al. Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity. J. Exp. Med. 212, 53–72 (2015).
Janssen, E., Zhu, M., Zhang, W., Koonpaew, S. & Zhang, W. LAB: a new membrane-associated adaptor molecule in B cell activation. Nat. Immunol. 4, 117–123 (2003).
Malhotra, S., Kovats, S., Zhang, W. & Coggeshall, K. M. Vav and Rac activation in B cell antigen receptor endocytosis involves Vav recruitment to the adapter protein LAB. J. Biol. Chem. 284, 36202–36212 (2009).
Trebak, M. & Kinet, J. P. Calcium signalling in T cells. Nat. Rev. Immunol. 19, 154–169 (2019).
Braun, J., Sha’afi, R. I. & Unanue, E. R. Crosslinking by ligands to surface immunoglobulin triggers mobilization of intracellular 45Ca2+ in B lymphocytes. J. Cell Biol. 82, 755–766 (1979).
Baba, Y. & Kurosaki, T. Role of calcium signaling in B cell activation and biology. Curr. Top. Microbiol. Immunol. 393, 143–174 (2016).
Matsumoto, A. K. et al. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173, 55–64 (1991).
Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. & Tedder, T. F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841–2850 (1992).
Fujimoto, M. et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13, 47–57 (2000).
Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K. & Kurosaki, T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13, 817–827 (2000).
Castello, A. et al. Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K–Akt pathway in B cells. Nat. Immunol. 14, 966–975 (2013).
Sicheri, F. & Kuriyan, J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7, 777–785 (1997).
Dai, X. et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Invest. 123, 2024–2036 (2013).
Nada, S., Okada, M., MacAuley, A., Cooper, J. A. & Nakagawa, H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351, 69–72 (1991).
de la Fuente-Garcı́a, M. A. et al. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91, 2800–2809 (1998).
Zhu, J. W., Brdicka, T., Katsumoto, T. R., Lin, J. & Weiss, A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 28, 183–196 (2008).
Getahun, A., Beavers, N. A., Larson, S. R., Shlomchik, M. J. & Cambier, J. C. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J. Exp. Med. 213, 751–769 (2016).
Smith, M. J. et al. Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity. JCI Insight 4, e123384 (2019).
Gabbiani, G., Chaponnier, C., Zumbe, A. & Vassalli, P. Actin and tubulin co-cap with surface immunoglobulins in mouse B lymphocytes. Nature 269, 697–698 (1977).
Schreiner, G. F., Fujiwara, K., Pollard, T. D. & Unanue, E. R. Redistribution of myosin accompanying capping of surface Ig. J. Exp. Med. 145, 1393–1398 (1977).
Liu, C. et al. Actin reorganization is required for the formation of polarized B cell receptor signalosomes in response to both soluble and membrane-associated antigens. J. Immunol. 188, 3237–3246 (2012).
Acknowledgements
S.E.D. is supported by the Danish National Research Foundation Centre of Excellence, CellPAT, the Center for Cellular Signal Patterns (DNRF135), the Lundbeck Foundation (R238-2016-2954), the LEO Foundation (LF-OC-22-000977), and the Independent Research Fund Denmark through a Sapere Aude Research Leader grant (9060-00038), as well as a Carlsberg Foundation Distinguished Fellowship (CF18-0446). P.T. is supported by the Wellcome Trust (grant 223196/Z/21/Z) and the UK Medical Research Council (grant MR/X009254/1).
Author information
Authors and Affiliations
Contributions
S.E.D. and P.T. co-wrote the first draft, revised and finalized the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Immunology thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Allostery
-
Derived from the Greek ‘allos’ meaning ‘other’ and ‘stereos’ meaning ‘solid, three-dimensional’. It describes the phenomenon whereby binding at one site causes effects transmitted through the protein to a distal site.
- Antigen
-
Originally defined as a substance able to elicit an antibody response, but since expanded to encompass targets that elicit a T-cell response. This definition does not include haptens, which in monovalent form and in the absence of a carrier would not elicit an antibody response. However, here in the context of BCR triggering, we loosely refer to antigens as substances that may trigger antigen-specific BCR activation, whether or not this would lead to a productive downstream antibody response.
- B-cell activation
-
The threshold activation of a B cell, driven by BCR signalling and/or auxiliary signalling pathways, such as those downstream of CD19/CD21/CD81, CD40 and cytokine receptors, and modified by inhibitory signalling from (for example) FcγRIIb, CD22, CD72 and LILRB.
- BCR engagement
-
Binding of antigen to the BCR. This may, or may not, trigger (activate) the BCR.
- BCR signalling
-
Describes the whole pathway triggered by antigen engagement of the BCR, and hence encompasses both BCR activation or triggering and signalling downstream of the BCR.
- BCR triggering
-
The event(s) that translate(s) antigen binding in the Fab region(s) to a signal on the intracellular side of the membrane.
- Epitope
-
The molecular determinant recognized by a given antibody/BCR (or T-cell receptor for peptide–MHC), often a smaller component of a given antigen.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Degn, S.E., Tolar, P. Towards a unifying model for B-cell receptor triggering. Nat Rev Immunol (2024). https://doi.org/10.1038/s41577-024-01073-x
Accepted:
Published:
DOI: https://doi.org/10.1038/s41577-024-01073-x